EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 18, Issue 1
ramusmedical
Volume 15 Issue 4

Precision Medicine: Targeted Therapy in Paediatric Oncology Patients

For several decades, cancer has been one most of the devastating diseases affecting paediatric patients. A huge number of clinical trials and research papers are aim...
24 January 2024 Volume 15 Issue 4 cancer | devastating
Continue Reading →
Volume 15 Issue 2

Enhancing Healthcare Through Improved Patient Labeling

When patients receive a prescription drug or biological product in an outpatient setting, it may be accompanied by one or more types of written information approved ...
6 July 2023 Volume 15 Issue 2 biological | Enhancing
Continue Reading →
Regional News

Pfizer’s COVID pill Paxlovid gets boost in Britain thanks to spot in national trial

Pfizer’s COVID-19 vaccine and antiviral show little sign of slowing down in the pandemic’s third year. Now, the company’s oral therapy is getting a boost across the A...
13 April 2022 Regional News Britain | cancer
Continue Reading →
Regional News

Zealand becomes a lesson in the rigors of commercialization as a slow launch triggers 90% staff cut, CEO exit

It wasn’t supposed to be this way. Zealand Pharma should be in the honeymoon glow of its first drug launch with a drug approved less than a year ago. Instead, it's lo...
4 April 2022 Regional News diabetes | FDA
Continue Reading →
Regional News

Biogen’s Aduhelm call to action backfires as CMS receives many more comments in favor of restrictive coverage: analyst

During a January Q&A call with investors, Biogen chief Michel Vounatsos pressed Aduhelm supporters to fight the Centers for Medicare & Medicaid Services’ (CMS...
2 February 2022 Regional News Aduhelm | Biogen
Continue Reading →
Regional News

Pfizer’s Cibinqo snags FDA approval to challenge Sanofi and Regeneron’s Dupixent in eczema

Look out, Sanofi and Regeneron: Pfizer is on the scene in atopic dermatitis with another blockbuster-to-be. Friday, the FDA approved the New York drugmaker's oral da...
18 January 2022 Regional News eczema | patients
Continue Reading →
Regional News

Idorsia scores FDA go-ahead for insomnia drug Quviviq to rival Merck’s Belsomra, Eisai’s Dayvigo

The FDA blessed Idorsia's Quviviq (daridorexant), a sleeping pill for those with insomnia. Because the FDA has recommended Idorsia to register Quviviq as a controlled...
11 January 2022 Regional News diagnosed | FDA
Continue Reading →
Regional News

Eyeing its post-Humira future, AbbVie angles for broader Rinvoq use in U.S., Europe

Despite classwide safety worries in the U.S., AbbVie is making strides in its quest to build immunology up-and-comer Rinvoq. AbbVie sent off applications to U.S. and...
11 January 2022 Regional News AbbVie | drug
Continue Reading →
Volume 13 Issue 5

Finding the Right Patients for Primary Care Clinical Studies

Automated Recruitment Platforms (ARPs) offer primary care clinicians and allied health professionals’ opportunities for more time-efficient ways to engage with and re...
18 October 2021 Volume 13 Issue 5 ARPs | Clinical Studies
Continue Reading →
Europe

Feedback from Parkinson’s Patients Can Help Improve Trial Recruitment, Retention, Study Says

Getting the perspective of Parkinson’s disease patients on their motivations and experiences participating in clinical trials can help increase recruitment and retent...
31 July 2018 Europe can | feedback
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte